Small molecule inhibitors of MCL-1 and uses thereof
This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having pyrazolopyridine structure which function as inhibitors of Mcl-1 protein, and their use as therapeutics for the treatment of cancer and other diseases.
1. A compound having Formula I:
including pharmaceutically acceptable salts, solvates, and/or prodrugs thereof;
wherein R1 is selected from the group consisting of from
wherein R2 is selected from the group consisting of
and
wherein R3 is selected from the group consisting of hydrogen, OH, OCH 3 OCH 2 CH 3 COOH, COOCH 3 COOCH 2 CH 3 ,
wherein X, Y, Z are independently N, C or CO.
2. The compound of claim 1 , wherein the compound is able to bind the BH3 binding pocket of an Mcl-1 protein.
3. The compound of claim 1 , wherein said compound is selected from the group consisting of
pharmaceutically acceptable carrier.
4. A pharmaceutical composition comprising a compound of claim 1 .